Price target upside
Nurix Therapeutics Price Target: +23.8% vs Current Price
NRIX target gap is +23.8% from $27.05 to $33.50. As of 2026-08-17.
Direct answer
Nurix Therapeutics's analyst target implies +23.8%.
The average target is $33.50 compared with a recorded current price of $27.05.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 17, 2026.
Get free Nurix Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $27.05
- Average price target
- $33.50
- High price target
- $45.00
- Low price target
- $25.00
- Low target gap
- -7.6%
- Target upside
- +23.8%
- High target gap
- +66.4%
- Target range width
- 73.9%
- Consensus rating
- Strong Buy
- Analysts
- 16
- Evidence date
- August 17, 2026
- Valid through
- August 24, 2026
Explore related company data
Read the frequently asked questions.
How much upside or downside does Nurix Therapeutics's average target imply?
Nurix Therapeutics's average target is $33.50 versus a recorded price of $27.05. The difference is +23.8%.
How far are Nurix Therapeutics's low and high targets from the recorded price?
The low target implies -7.6%, while the high target implies +66.4%.
How many analysts are included in Nurix Therapeutics's consensus?
The verified consensus includes 16 analysts.
How is Nurix Therapeutics's target upside or downside calculated?
The average target of $33.50 is divided by the recorded price of $27.05, then one is subtracted to produce +23.8%. This does not guarantee a future return.
When was Nurix Therapeutics's analyst forecast verified?
The data was verified on 2026-08-17. The dataset is valid through 2026-08-24.